Abstract:AIM: The study of immune response of open versus laparoscopical total mesorectal excision with anal sphincter preservation in patients with rectal cancer has not been reported yet. The dissected retroperitoneal area that contacts directly with carbon dioxide is extensive in laparoscopic total mesorectal excision with anal sphincter preservation surgery. It is important to clarify whether the immune response of laparoscopic total mesorectal excision with anal sphincter preservation (LTME with ASP) in patients with rectal cancer is suppressed more severely than that of open surgery (OTME with ASP). This study was designed to compare the immune functions after laparoscopic and open total mesorectal excision with anal sphincter preservation for rectal cancer.METHODS: This study involved 45 patients undergoing laparoscopic (n=20) and open (n=25) total mesorectal excisions with anal sphincter preservation for rectal cancer. Serum interleukin-2 (IL-2), interleukin-6 (IL-6), tumor necrosis factor alpha (TNFalpha) were assayed preoperatively and on days 1 and 5 postoperatively. CD3(+) and CD56(+) T lymphocyte count, CD3(-) and CD56(+) natural killer cell (NK) count and immunoglobulin (IgG/IgM/IgA) were assayed preoperatively and on day 5 postoperatively. The numbers of CD3(+) and CD56(+) T lymphocytes and CD3(-) and CD56(+) NK cells were counted using flow cytometry. An enzyme-linked immunosorbent assay (ELISA) was used for IL-2, IL-6 and TNFalpha determination. And IgG, IgM, and IgA were assayed using immunonephelometry.RESULTS: The demographic data of the two groups had no difference. The preoperative levels of CD3(+) and CD56(+) T lymphocyte count, CD3(-) and CD56(+) NK count, serum IgG, IgM, IgA, IL-2, IL-6 and TNFalpha also had no significant difference in the two groups (P>0.05). The CD3(+) and CD56(+) T lymphocyte counts had no obvious changes after surgery in laparoscopic (d=-0.79+/-3.83%) and open (d=0.42+/-2.09%) groups. The CD3(-) and CD56(+) NK counts were decreased postoperatively in both laparoscopic (d=-7.23+/-11.33%) and open (d=-9.21+/-13.93%) groups. The differences of the determined values of serum IgG, IgM and IgA on the fifth day after operation subtracted those before operation were -2.56+/-2.14 g/L, -252.35+/-392.94 mg/L, -506.15+/-912.24 mg/L in laparoscopic group, and -1.81+/-2.10 g/L, -282.72+/-356.75 mg/L, -252.20+/-396.28 mg/L in open group, respectively. The levels of IL-2 were decreased after operation in both groups. However, the levels of IL-6 were decreased after laparoscopic surgery (d(1)=-23.14+/-263.97 ng/L and d(5)=-40.08+/-272.03 ng/L), and increased after open surgery (d(1)=27.38+/-129.14 ng/L and d(5)=21.67+/-234.31 ng/L). The TNFalpha levels were not elevated after surgery in both groups. There were no significant differences in the numbers of CD3(+) and CD56(+) T lymphocytes and CD3(-) and CD56(+) NK cells, the levels of IgG, IgM, IgA, IL-2, IL-6 and TNFalpha between the two groups (P>0.05).CONCLUSION: There are no differences in immune responses between the patients having laparoscopic total mesorectal excision with anal sphincter preservation and those undergone open surgery for rectal cancer.

Quality of Life Outcomes Following Laparoscopic Total Mesorectal Excision for Low Rectal Cancers: A Clinical Control Study

Evaluation of Life Quality Following Laparoscopic Total Mesorectal Excision for Low Rectal Cancers:A Clinical Control Study

The application of laparoscopic total mesorectal excision with preservation of anal sphincter for rectal cancer

Application of Laparoscopic Total Mesorectal Excision Combined with Sphincter-Preserving Surgery in Low or Ultralow Rectal Cancer

Evaluation of Short-Term Outcomes of Laparoscopic and Open Total Mesorectal Excision for Mid and Distal Rectal Cancer

Short-term Outcomes of Laparoscopic Total Mesorectal Excision Compared to Open Surgery.

Long-term outcome of laparoscopic total mesorectal excision for middle and low rectal cancer.

Quality of Life After Surgery for Rectal Cancer: a Comparison of Functional Outcomes After Transanal and Laparoscopic Approaches

Comparison of patient-reported quality of life and functional outcomes following laparoscopic and transanal total mesorectal excision of rectal cancer

Laparoscopic versus open total mesorectal excision with anal sphincter preservation for low rectal cancer

Quality of life after rectal cancer surgery: differences between laparoscopic and transanal total mesorectal excision

Laparoscopic Vs Open Total Mesorectal Excision With Anal Sphincter Preservation For Low Rectal Cancer

Laparoscopic Versus Open Total Mesorectal Exision with Anal Sphincter Preservation for Low Rectal Cancer:A Randomized Trial on Short- Term Outcomes

Long-term outcomes of total mesorectai excision for rectal cancer by laparoscopic and open surgery

Clinical comparison of laparoscopic and open total mesorectal excision for sphincter preservation in the treatment of lower rectal cancer

Laparoscopic Total Mesorectal Excision versus Open Total Mesorectal Excision for Rectal Cancer: A Meta-Analysis

Impact of a Laparoscopic Resection on the Quality of Life in Rectal Cancer Patients: Results of 135 Patients

A Controlled Study on the Efficacy and Quality of Life of Laparoscopic Intersphincteric Resection (ISR) and Extralevator Abdominoperineal Resection (ELAPE) in the Treatment of Extremely Low Rectal Cancer.

Laparoscopic Total Mesorectal Excision of Low Rectal Cancer with Preservation of Anal Sphincter: A Report of 82 Cases

Comparative Evaluation of Immune Response after Laparoscopical and Open Total Mesorectal Excisions with Anal Sphincter Preservation in Patients with Rectal Cancer

Clinical Comparison of Laparoscope Versus Laparotomy Total Mesorectal Excision with Anal Sphincter Preservation for Low Rectal Cancer